Please Note:
This profile was automatically generated using 7 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 7 references found on the Internet. This information has not been verified. Learn more...
View all 7 references Web References
-
1. www.cbinet.com
www.cbinet.com/show_conference - [Cached]Published on: 2/18/2008 Last Visited: 2/20/2008
Hubert C. Chen, M.D., Senior Director of Clinical Research, Amylin Pharmaceuticals Inc. -
2. 2006 NMS Conference Speakers
www.nmsociety.org/speakers06.h - [Cached]Published on: 7/18/2006 Last Visited: 10/14/2007
Hubert C. Chen, M.D., is an Associate Director of Medical Sciences at Amgen and an Assistant Clinical Professor of Medicine at the University of California, San Francisco. Before joining Amgen, he was a Staff Research Investigator at the Gladstone Institutes in San Francisco, where he investigated the effects of modulating triglyceride synthesis on energy and glucose metabolism in mouse models. His current responsibilities include creating and executing preclinical and early clinical strategies for type 2 diabetes programs, as well as designing and implementing proof-of-concept studies and biomarker discovery efforts in obesity, osteoporosis, and muscle atrophy programs. -
3. Obesity Drug Development Summit - CBI Research, Inc.
www.cbinet.com/show_conference - [Cached]Published on: 7/21/2005 Last Visited: 4/17/2006
Hubert C. Chen, M.D., Associate Director of Medical Sciences, Amgen Inc.

